ewsba.se
Bonus shares alert: Shares of Titan Biotech Limited will remain in focus next week due to their upcoming bonus issue record date. The speciality chemicals stock has announced the issuance of bonus shares in a 1:4 ratio. The corporate action comes months after the firm executed a stock split.
Titan Biotech's share price ended 1.5% higher after seeing 3.64% return over the week. Here are all the details about the corporate action announced by the company.
The board of directors of Titan Biotech had considered and approved a bonus issue in the ratio of 1:4. This means that every eligible investor will receive one fully paid-up equity share (of face value ₹2) for every four existing shares held by them.
Titan Biotech’s board of directors has set Friday, October 23, as the record date to determine the eligibility of shareholders for the payout.
“We hereby inform you that the Board of Directors has fixed the ‘Record Date’ as Friday, October 23, 2026 (T Day) for the purpose of ascertaining the eligibility of shareholders entitled for allotment of Bonus Equity Shares,” the company stated.
The company has fixed Monday, October 26, as the final day for allotment of “1,03,29,625 fully paid-up Bonus Equity Shares of Rs. 2/- each”. The bonus shares will be issued in the proportion of 1:4. As per the BSE filing, paid-up bonus equity shares will be available for trading on the next working day from the date of allotment, i.e., Tuesday, October 27, 2026.
The stock closed 1.57% higher at ₹406.90 per share on BSE with a market capitalisation of ₹1,681.25 crore on Friday. The speciality chemicals stock, with a return on equity (ROE) of 22.35%, has delivered 91.44% return in 2026 so far. The stock has surged 57.72% in one year, 147% in two years, and delivered around 453.30% return in three years.
Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.